A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to research from a phase I clinical trial ...

A new clinical trial is testing whether giving immunotherapy before surgery—while the tumor is still in place—could finally ...

Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...

Patients received an initial intratumoral injection of RP1 with up to 7 additional doses every 2 weeks, plus 240 mg nivolumab ...

Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment for international patients, outlining key developments in ...

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...

Experts decode NSCLC PD‑L1 trials, when immunotherapy alone works, why crossover matters, and who still benefits from adding chemotherapy. We have now covered several treatment approaches for patients ...

Among US patients diagnosed with head and neck cancer (HNC) before age 65, immunotherapy uptake has been slow, inching up from 2.3% of patients in 2017 to 2.8% in 2022. Immune-related adverse events ...

The idea that cancer treatment might work better at certain times of day has circulated for decades but has rarely faced rigorous clinical testing. Now, a randomized trial of 210 people with advanced ...

An Israeli court has rejected a request to allow a five-year-old Palestinian boy suffering from aggressive cancer to receive life-saving treatment, ruling that his registration as a resident of the ...

Immunotherapy has transformed the field of medicine. In the context of cancer, immune cells become dysregulated and lose the ability to recognize and target the tumor. The tumor reshapes its ...